Recent advances in hybrid Positron Emission Tomography (PET) Magnetic Resonance (MR) technology have enabled simultaneous imaging with both modalities. Sarcoidosis is a granulomatous disease that, when involving the heart has a poor prognosis. However, cardiac sarcoidosis has been shown to respond to immunosuppressive therapy. Currently, both late gadolinium enhancement (LGE)-MR and 18F-fluorodeoxyglucose (18F-FDG)-PET are used separately to evaluate the disease yet a clear diagnosis is not easily achieved. In this work, we investigate the potential improvement in evaluation with combined 18F-FDG-PET/MR imaging.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords